Header Logo

Connection

ELENI EFSTATHIOU to Indazoles

Back to Details
This is a "connection" page, showing publications ELENI EFSTATHIOU has written about Indazoles.
ELENI EFSTATHIOU
Connection Strength
0.043
Indazoles
  1. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial. Lancet Oncol. 2022 03; 23(3):362-373.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.